Search Results Search Sort by RelevanceMost Recent Case and Commentary May 2022 Do You Know How to Assess Risks Posed by Over-the-Counter Vitamin A Supplements? Dina H. Zamil, Emily K. Burns, Ariadna Perez-Sanchez, MD, and Rajani Katta, MD Label analysis is key to educating patients about risks of vitamin A-containing supplements. AMA J Ethics. 2022;24(5):E376-381. doi: 10.1001/amajethics.2022.376. Case and Commentary Mar 2023 How Should Clinicians and Researchers in Government Respond to Threats to Their Offices? Daphne Mlachila, MD, MPH During the COVID-19 pandemic, clinician policy makers have faced unprecedented challenges to their roles in governance. AMA J Ethics. 2023;25(3):E172-178. doi: 10.1001/amajethics.2023.172. Case and Commentary Aug 2005 Hoping for the Best, Preparing for the Worst: Physician to Patient in Clinical Trial Frederic W. Platt, MD Virtual Mentor. 2005;7(8):541-546. doi: 10.1001/virtualmentor.2005.7.8.ccas2-0508. Case and Commentary Nov 2004 Clinical Trials and End-of-Life Decision Making, Commentary 1 David S. Alberts, MD Virtual Mentor. 2004;6(11):477-479. doi: 10.1001/virtualmentor.2004.6.11.ccas1-0411. Case and Commentary Nov 2004 Clinical Trials and End-of-Life Decision Making, Commentary 2 Lucy Godley, MD, PhD Virtual Mentor. 2004;6(11):479-481. doi: 10.1001/virtualmentor.2004.6.11.ccas1-0411. Case and Commentary Nov 2004 Heads or Tails: Randomized Placebo-Controlled Trials, Commentary 1 Charles Weijer, MD, PhD Virtual Mentor. 2004;6(11):482-484. doi: 10.1001/virtualmentor.2004.6.11.ccas2-0411. Case and Commentary Nov 2004 Heads or Tails: Randomized Placebo-Controlled Trials, Commentary 2 Karen Kreiner, MD Virtual Mentor. 2004;6(11):484-485. doi: 10.1001/virtualmentor.2004.6.11.ccas2-0411. Case and Commentary Nov 2004 Who Is That? Expanding the Clinical Encounter Vijaya Arekapudi, MD Virtual Mentor. 2004;6(11):486-487. doi: 10.1001/virtualmentor.2004.6.11.ccas3-0411. Case and Commentary Nov 2023 How Should Organizations and Clinicians Help Marginalized Patients Manage Loneliness as a Harm of Climate Change? Lisa Fuller, PhD Individualistic approaches to the collective problem of climate change are ethically inadequate. AMA J Ethics. 2023;25(11):E802-808. doi: 10.1001/amajethics.2023.802. Case and Commentary Dec 2015 Enrolling Research Participants in Private Practice: Conflicts of Interest, Consistency, Therapeutic Misconception, and Informed Consent Armand H. Matheny Antommaria, MD, PhD and Kristin Stanley Bramlage, MD Advice for enrolling patients in clinical trials. AMA J Ethics. 2015;17(12):1122-1126. doi: 10.1001/journalofethics.2015.17.12.ecas3-1512. Pagination Current page 1 Page 2 Next page Next › Last page Last »
Case and Commentary May 2022 Do You Know How to Assess Risks Posed by Over-the-Counter Vitamin A Supplements? Dina H. Zamil, Emily K. Burns, Ariadna Perez-Sanchez, MD, and Rajani Katta, MD Label analysis is key to educating patients about risks of vitamin A-containing supplements. AMA J Ethics. 2022;24(5):E376-381. doi: 10.1001/amajethics.2022.376.
Case and Commentary Mar 2023 How Should Clinicians and Researchers in Government Respond to Threats to Their Offices? Daphne Mlachila, MD, MPH During the COVID-19 pandemic, clinician policy makers have faced unprecedented challenges to their roles in governance. AMA J Ethics. 2023;25(3):E172-178. doi: 10.1001/amajethics.2023.172.
Case and Commentary Aug 2005 Hoping for the Best, Preparing for the Worst: Physician to Patient in Clinical Trial Frederic W. Platt, MD Virtual Mentor. 2005;7(8):541-546. doi: 10.1001/virtualmentor.2005.7.8.ccas2-0508.
Case and Commentary Nov 2004 Clinical Trials and End-of-Life Decision Making, Commentary 1 David S. Alberts, MD Virtual Mentor. 2004;6(11):477-479. doi: 10.1001/virtualmentor.2004.6.11.ccas1-0411.
Case and Commentary Nov 2004 Clinical Trials and End-of-Life Decision Making, Commentary 2 Lucy Godley, MD, PhD Virtual Mentor. 2004;6(11):479-481. doi: 10.1001/virtualmentor.2004.6.11.ccas1-0411.
Case and Commentary Nov 2004 Heads or Tails: Randomized Placebo-Controlled Trials, Commentary 1 Charles Weijer, MD, PhD Virtual Mentor. 2004;6(11):482-484. doi: 10.1001/virtualmentor.2004.6.11.ccas2-0411.
Case and Commentary Nov 2004 Heads or Tails: Randomized Placebo-Controlled Trials, Commentary 2 Karen Kreiner, MD Virtual Mentor. 2004;6(11):484-485. doi: 10.1001/virtualmentor.2004.6.11.ccas2-0411.
Case and Commentary Nov 2004 Who Is That? Expanding the Clinical Encounter Vijaya Arekapudi, MD Virtual Mentor. 2004;6(11):486-487. doi: 10.1001/virtualmentor.2004.6.11.ccas3-0411.
Case and Commentary Nov 2023 How Should Organizations and Clinicians Help Marginalized Patients Manage Loneliness as a Harm of Climate Change? Lisa Fuller, PhD Individualistic approaches to the collective problem of climate change are ethically inadequate. AMA J Ethics. 2023;25(11):E802-808. doi: 10.1001/amajethics.2023.802.
Case and Commentary Dec 2015 Enrolling Research Participants in Private Practice: Conflicts of Interest, Consistency, Therapeutic Misconception, and Informed Consent Armand H. Matheny Antommaria, MD, PhD and Kristin Stanley Bramlage, MD Advice for enrolling patients in clinical trials. AMA J Ethics. 2015;17(12):1122-1126. doi: 10.1001/journalofethics.2015.17.12.ecas3-1512.